Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.40 | -19.17 |
| PEG Ratio (TTM) | -0.02 | -5.61 |
| P/S Ratio (TTM) | 1.04 | 41.30 |
| P/B Ratio (TTM) | 2.85 | 5.67 |
| P/FCF Ratio (TTM) | -3.87 | -148.36 |
| Price to 5YR AVG Earnings Ratio | -1.33 | -33.81 |
| Price to 5YR AVG FCF Ratio | -17.37 | -1.26 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -27.21% | 291.32% |
| ROE (TTM) | -119.53% | -4,280.27% |
| Net Profit Margin (TTM) | -72.72% | -1,106.71% |
| ROIC 5YR AVG | -240.31% | -16.06% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -63.10% | -319.00% | -407.11% |
| Revenue | 50.09% | 12.47% | 9.67% |
| Net Income | -74.50% | 177,305.64% | 106,109.59% |
| Cash Flow | 40.98% | -69,269.86% | -41,552.57% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.19 | 4.95 |
| Quick Ratio (TTM) | 0.14 | 4.93 |
| D/E Ratio (TTM) | 0.21 | 1.29 |
| Interest Coverage (TTM) | -3.08 | -11.14 |
| Piotroski F-Score | 4 | 3 |
| Altman Z-Score | N/A | 21.20 |
| LTL to 5YR AVG FCF | -0.31 | -0.53 |
| Shares Outstanding Growth 5YR AVG | 53.32% | 887.86% |